APO Research

APO RESEARCH · REPORT

IVIg Liquid

Selected research

Industry Growth & Trends

Global IVIg Liquid Industry Growth and Trends Forecast to 2032

Market perspective

The global IVIg Liquid market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for IVIg Liquid is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for IVIg Liquid is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for IVIg Liquid is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of IVIg Liquid include Takeda, Sichuan Yuanda Shuyang, Shanghai RAAS, Hualan Bio, Octapharma, LFB Group, Kedrion, Grifols and CSL, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global IVIg Liquid market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The IVIg Liquid market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global IVIg Liquid market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to IVIg Liquid.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global IVIg Liquid market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

IVIg Liquid Market by Company

Takeda

Sichuan Yuanda Shuyang

Shanghai RAAS

Hualan Bio

Octapharma

LFB Group

Kedrion

Grifols

CSL

CNBG

CBPO

BPL

Biotest

IVIg Liquid Segment by Type

50ml

25ml

IVIg Liquid Segment by Application

Autoimmune Disease

Immunodeficiency

Acute Infection

IVIg Liquid Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global IVIg Liquid market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of IVIg Liquid and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of IVIg Liquid.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of IVIg Liquid manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of IVIg Liquid in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 50ml Table 2. Major Company of 25ml Table 3. Global IVIg Liquid Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global IVIg Liquid Sales by Type (2021-2026) & (k units) Table 5. Global IVIg Liquid Sales Market Share in Volume by Type (2021-2026) Table 6. Global IVIg Liquid Sales by Type (2021-2026) & (US$ Million) Table 7. Global IVIg Liquid Sales Market Share in Value by Type (2021-2026) Table 8. Global IVIg Liquid Price by Type (2021-2026) & (US$/unit) Table 9. Global IVIg Liquid Sales by Type (2027-2032) & (k units) Table 10. Global IVIg Liquid Sales Market Share in Volume by Type (2027-2032) Table 11. Global IVIg Liquid Sales by Type (2027-2032) & (US$ Million) Table 12. Global IVIg Liquid Sales Market Share in Value by Type (2027-2032) Table 13. Global IVIg Liquid Price by Type (2027-2032) & (US$/unit) Table 14. North America IVIg Liquid Sales by Type (2021-2026) & (k units) Table 15. North America IVIg Liquid Sales by Type (2021-2026) & (US$ Million) Table 16. Europe IVIg Liquid Sales by Type (2021-2026) & (k units) Table 17. Europe IVIg Liquid Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific IVIg Liquid Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific IVIg Liquid Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America IVIg Liquid Sales by Type (2021-2026) & (k units) Table 21. Latin America IVIg Liquid Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa IVIg Liquid Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa IVIg Liquid Sales by Type (2021-2026) & (US$ Million) Table 24. IVIg Liquid Industry Trends Table 25. IVIg Liquid Industry Drivers Table 26. IVIg Liquid Industry Opportunities and Challenges Table 27. IVIg Liquid Industry Restraints Table 28. Global IVIg Liquid Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global IVIg Liquid Revenue Market Share by Company (2021-2026) Table 30. Global IVIg Liquid Sales by Company (2021-2026) & (k units) Table 31. Global IVIg Liquid Sales Share by Company (2021-2026) Table 32. Global IVIg Liquid Market Price by Company (2021-2026) & (US$/unit) Table 33. Global IVIg Liquid Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global IVIg Liquid Major Company Production Sites and Headquarters Table 35. Global IVIg Liquid Company, Product Type & Application Table 36. Global IVIg Liquid Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global IVIg Liquid by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global IVIg Liquid Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global IVIg Liquid Sales by Region (2021-2026) & (k units) Table 41. Global IVIg Liquid Sales Market Share in Volume by Region (2021-2026) Table 42. Global IVIg Liquid Sales by Region (2021-2026) & (US$ Million) Table 43. Global IVIg Liquid Sales Market Share in Value by Region (2021-2026) Table 44. Global IVIg Liquid Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global IVIg Liquid Sales by Region (2027-2032) & (k units) Table 46. Global IVIg Liquid Sales Market Share in Volume by Region (2027-2032) Table 47. Global IVIg Liquid Sales by Region (2027-2032) & (US$ Million) Table 48. Global IVIg Liquid Sales Market Share in Value by Region (2027-2032) Table 49. Global IVIg Liquid Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global IVIg Liquid Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global IVIg Liquid Sales by Application (2021-2026) & (k units) Table 52. Global IVIg Liquid Sales Market Share in Volume by Application (2021-2026) Table 53. Global IVIg Liquid Sales by Application (2021-2026) & (US$ Million) Table 54. Global IVIg Liquid Sales Market Share in Value by Application (2021-2026) Table 55. Global IVIg Liquid Price by Application (2021-2026) & (US$/unit) Table 56. Global IVIg Liquid Sales by Application (2027-2032) & (k units) Table 57. Global IVIg Liquid Sales Market Share in Volume by Application (2027-2032) Table 58. Global IVIg Liquid Sales by Application (2027-2032) & (US$ Million) Table 59. Global IVIg Liquid Sales Market Share in Value by Application (2027-2032) Table 60. Global IVIg Liquid Price by Application (2027-2032) & (US$/unit) Table 61. North America IVIg Liquid Sales by Application (2021-2026) & (k units) Table 62. North America IVIg Liquid Sales by Application (2021-2026) & (US$ Million) Table 63. Europe IVIg Liquid Sales by Application (2021-2026) & (k units) Table 64. Europe IVIg Liquid Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific IVIg Liquid Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific IVIg Liquid Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America IVIg Liquid Sales by Application (2021-2026) & (k units) Table 68. Latin America IVIg Liquid Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa IVIg Liquid Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa IVIg Liquid Sales by Application (2021-2026) & (US$ Million) Table 71. Takeda Company Information Table 72. Takeda Business Overview Table 73. Takeda IVIg Liquid Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Takeda IVIg Liquid Product Portfolio Table 75. Takeda Recent Development Table 76. Sichuan Yuanda Shuyang Company Information Table 77. Sichuan Yuanda Shuyang Business Overview Table 78. Sichuan Yuanda Shuyang IVIg Liquid Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Sichuan Yuanda Shuyang IVIg Liquid Product Portfolio Table 80. Sichuan Yuanda Shuyang Recent Development Table 81. Shanghai RAAS Company Information Table 82. Shanghai RAAS Business Overview Table 83. Shanghai RAAS IVIg Liquid Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Shanghai RAAS IVIg Liquid Product Portfolio Table 85. Shanghai RAAS Recent Development Table 86. Hualan Bio Company Information Table 87. Hualan Bio Business Overview Table 88. Hualan Bio IVIg Liquid Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Hualan Bio IVIg Liquid Product Portfolio Table 90. Hualan Bio Recent Development Table 91. Octapharma Company Information Table 92. Octapharma Business Overview Table 93. Octapharma IVIg Liquid Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Octapharma IVIg Liquid Product Portfolio Table 95. Octapharma Recent Development Table 96. LFB Group Company Information Table 97. LFB Group Business Overview Table 98. LFB Group IVIg Liquid Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. LFB Group IVIg Liquid Product Portfolio Table 100. LFB Group Recent Development Table 101. Kedrion Company Information Table 102. Kedrion Business Overview Table 103. Kedrion IVIg Liquid Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. Kedrion IVIg Liquid Product Portfolio Table 105. Kedrion Recent Development Table 106. Grifols Company Information Table 107. Grifols Business Overview Table 108. Grifols IVIg Liquid Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. Grifols IVIg Liquid Product Portfolio Table 110. Grifols Recent Development Table 111. CSL Company Information Table 112. CSL Business Overview Table 113. CSL IVIg Liquid Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. CSL IVIg Liquid Product Portfolio Table 115. CSL Recent Development Table 116. CNBG Company Information Table 117. CNBG Business Overview Table 118. CNBG IVIg Liquid Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 119. CNBG IVIg Liquid Product Portfolio Table 120. CNBG Recent Development Table 121. CBPO Company Information Table 122. CBPO Business Overview Table 123. CBPO IVIg Liquid Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 124. CBPO IVIg Liquid Product Portfolio Table 125. CBPO Recent Development Table 126. BPL Company Information Table 127. BPL Business Overview Table 128. BPL IVIg Liquid Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 129. BPL IVIg Liquid Product Portfolio Table 130. BPL Recent Development Table 131. Biotest Company Information Table 132. Biotest Business Overview Table 133. Biotest IVIg Liquid Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 134. Biotest IVIg Liquid Product Portfolio Table 135. Biotest Recent Development Table 136. North America IVIg Liquid Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 137. North America IVIg Liquid Sales by Country (2021-2026) & (k units) Table 138. North America IVIg Liquid Sales Market Share by Country (2021-2026) Table 139. North America IVIg Liquid Sales Forecast by Country (2027-2032) & (k units) Table 140. North America IVIg Liquid Sales Market Share Forecast by Country (2027-2032) Table 141. North America IVIg Liquid Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. North America IVIg Liquid Market Size by Country (2021-2026) & (US$ Million) Table 143. North America IVIg Liquid Market Share by Country (2021-2026) Table 144. North America IVIg Liquid Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. North America IVIg Liquid Market Share Forecast by Country (2027-2032) Table 146. Europe IVIg Liquid Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 147. Europe IVIg Liquid Sales by Country (2021-2026) & (k units) Table 148. Europe IVIg Liquid Sales Market Share by Country (2021-2026) Table 149. Europe IVIg Liquid Sales Forecast by Country (2027-2032) & (k units) Table 150. Europe IVIg Liquid Sales Market Share Forecast by Country (2027-2032) Table 151. Europe IVIg Liquid Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Europe IVIg Liquid Market Size by Country (2021-2026) & (US$ Million) Table 153. Europe IVIg Liquid Market Share by Country (2021-2026) Table 154. Europe IVIg Liquid Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Europe IVIg Liquid Market Share Forecast by Country (2027-2032) Table 156. Asia-Pacific IVIg Liquid Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 157. Asia-Pacific IVIg Liquid Sales by Country (2021-2026) & (k units) Table 158. Asia-Pacific IVIg Liquid Sales Market Share by Country (2021-2026) Table 159. Asia-Pacific IVIg Liquid Sales Forecast by Country (2027-2032) & (k units) Table 160. Asia-Pacific IVIg Liquid Sales Market Share Forecast by Country (2027-2032) Table 161. Asia-Pacific IVIg Liquid Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Asia-Pacific IVIg Liquid Market Size by Country (2021-2026) & (US$ Million) Table 163. Asia-Pacific IVIg Liquid Market Share by Country (2021-2026) Table 164. Asia-Pacific IVIg Liquid Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Asia-Pacific IVIg Liquid Market Share Forecast by Country (2027-2032) Table 166. Latin America IVIg Liquid Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 167. Latin America IVIg Liquid Sales by Country (2021-2026) & (k units) Table 168. Latin America IVIg Liquid Sales Market Share by Country (2021-2026) Table 169. Latin America IVIg Liquid Sales Forecast by Country (2027-2032) & (k units) Table 170. Latin America IVIg Liquid Sales Market Share Forecast by Country (2027-2032) Table 171. Latin America IVIg Liquid Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Latin America IVIg Liquid Market Size by Country (2021-2026) & (US$ Million) Table 173. Latin America IVIg Liquid Market Share by Country (2021-2026) Table 174. Latin America IVIg Liquid Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Latin America IVIg Liquid Market Share Forecast by Country (2027-2032) Table 176. Middle East and Africa IVIg Liquid Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 177. Middle East and Africa IVIg Liquid Sales by Country (2021-2026) & (k units) Table 178. Middle East and Africa IVIg Liquid Sales Market Share by Country (2021-2026) Table 179. Middle East and Africa IVIg Liquid Sales Forecast by Country (2027-2032) & (k units) Table 180. Middle East and Africa IVIg Liquid Sales Market Share Forecast by Country (2027-2032) Table 181. Middle East and Africa IVIg Liquid Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Middle East and Africa IVIg Liquid Market Size by Country (2021-2026) & (US$ Million) Table 183. Middle East and Africa IVIg Liquid Market Share by Country (2021-2026) Table 184. Middle East and Africa IVIg Liquid Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Middle East and Africa IVIg Liquid Market Share Forecast by Country (2027-2032) Table 186. Key Raw Materials Table 187. Raw Materials Key Suppliers Table 188. IVIg Liquid Distributors List Table 189. IVIg Liquid Customers List Table 190. Research Programs/Design for This Report Table 191. Authors List of This Report Table 192. Secondary Sources Table 193. Primary Sources List of Figures Figure 1. IVIg Liquid Image Figure 2. Global IVIg Liquid Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global IVIg Liquid Market Size (2021-2032) & (US$ Million) Figure 4. Global IVIg Liquid Sales (2021-2032) & (k units) Figure 5. 50ml Image Figure 6. Global 50ml Sales YoY Growth (2021-2032) & (k units) Figure 7. 25ml Image Figure 8. Global 25ml Sales YoY Growth (2021-2032) & (k units) Figure 9. Global IVIg Liquid Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global IVIg Liquid Market Share by Type 2025 VS 2032 Figure 11. North America IVIg Liquid Sales Market Share in Volume by Type in 2025 Figure 12. North America IVIg Liquid Sales Market Share in Value by Type in 2025 Figure 13. Europe IVIg Liquid Sales Market Share in Volume by Type in 2025 Figure 14. Europe IVIg Liquid Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific IVIg Liquid Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific IVIg Liquid Sales Market Share in Value by Type in 2025 Figure 17. Latin America IVIg Liquid Sales Market Share in Volume by Type in 2025 Figure 18. Latin America IVIg Liquid Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa IVIg Liquid Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa IVIg Liquid Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 IVIg Liquid Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Autoimmune Disease Image Figure 24. Global Autoimmune Disease Sales YoY Growth (2021-2032) & (k units) Figure 25. Immunodeficiency Image Figure 26. Global Immunodeficiency Sales YoY Growth (2021-2032) & (k units) Figure 27. Acute Infection Image Figure 28. Global Acute Infection Sales YoY Growth (2021-2032) & (k units) Figure 29. Global IVIg Liquid Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global IVIg Liquid Market Share by Application 2025 VS 2032 Figure 31. North America IVIg Liquid Sales Market Share in Volume by Application in 2025 Figure 32. North America IVIg Liquid Sales Market Share in Value by Application in 2025 Figure 33. Europe IVIg Liquid Sales Market Share in Volume by Application in 2025 Figure 34. Europe IVIg Liquid Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific IVIg Liquid Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific IVIg Liquid Sales Market Share in Value by Application in 2025 Figure 37. Latin America IVIg Liquid Sales Market Share in Volume by Application in 2025 Figure 38. Latin America IVIg Liquid Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa IVIg Liquid Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa IVIg Liquid Sales Market Share in Value by Application in 2025 Figure 41. North America IVIg Liquid Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 42. North America IVIg Liquid Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America IVIg Liquid Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America IVIg Liquid Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe IVIg Liquid Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. Europe IVIg Liquid Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe IVIg Liquid Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe IVIg Liquid Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific IVIg Liquid Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Asia-Pacific IVIg Liquid Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific IVIg Liquid Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific IVIg Liquid Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America IVIg Liquid Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Latin America IVIg Liquid Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America IVIg Liquid Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America IVIg Liquid Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa IVIg Liquid Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Middle East and Africa IVIg Liquid Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa IVIg Liquid Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa IVIg Liquid Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. IVIg Liquid Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. IVIg Liquid Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • 50ml
  • 25ml
Applications
  • Autoimmune Disease
  • Immunodeficiency
  • Acute Infection
Companies covered
  • Takeda
  • Sichuan Yuanda Shuyang
  • Shanghai RAAS
  • Hualan Bio
  • Octapharma
  • LFB Group
  • Kedrion
  • Grifols
  • CSL
  • CNBG
  • CBPO
  • BPL
  • Biotest

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global IVIg Liquid Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global IVIg Liquid Sales Estimates and Forecasts (2021-2032)
  5. 1.3 IVIg Liquid Market by Type
  6. 1.3.1 50ml
  7. 1.3.2 25ml
  8. 1.4 Global IVIg Liquid Market Size by Type
  9. 1.4.1 Global IVIg Liquid Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global IVIg Liquid Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global IVIg Liquid Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America IVIg Liquid Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe IVIg Liquid Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific IVIg Liquid Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America IVIg Liquid Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa IVIg Liquid Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 IVIg Liquid Industry Trends
  2. 2.2 IVIg Liquid Industry Drivers
  3. 2.3 IVIg Liquid Industry Opportunities and Challenges
  4. 2.4 IVIg Liquid Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by IVIg Liquid Revenue (2021-2026)
  2. 3.2 Global Top Players by IVIg Liquid Sales (2021-2026)
  3. 3.3 Global Top Players by IVIg Liquid Price (2021-2026)
  4. 3.4 Global IVIg Liquid Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global IVIg Liquid Major Company Production Sites & Headquarters
  6. 3.6 Global IVIg Liquid Company, Product Type & Application
  7. 3.7 Global IVIg Liquid Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global IVIg Liquid Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 IVIg Liquid Players Market Share by Revenue in 2025
  11. 3.8.3 2025 IVIg Liquid Tier 1, Tier 2, and Tier 3
4 IVIg Liquid Regional Status and Outlook
  1. 4.1 Global IVIg Liquid Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global IVIg Liquid Historic Market Size by Region
  3. 4.2.1 Global IVIg Liquid Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global IVIg Liquid Sales in Value by Region (2021-2026)
  5. 4.2.3 Global IVIg Liquid Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global IVIg Liquid Forecasted Market Size by Region
  7. 4.3.1 Global IVIg Liquid Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global IVIg Liquid Sales in Value by Region (2027-2032)
  9. 4.3.3 Global IVIg Liquid Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 IVIg Liquid by Application
  1. 5.1 IVIg Liquid Market by Application
  2. 5.1.1 Autoimmune Disease
  3. 5.1.2 Immunodeficiency
  4. 5.1.3 Acute Infection
  5. 5.2 Global IVIg Liquid Market Size by Application
  6. 5.2.1 Global IVIg Liquid Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global IVIg Liquid Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global IVIg Liquid Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America IVIg Liquid Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe IVIg Liquid Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific IVIg Liquid Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America IVIg Liquid Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa IVIg Liquid Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Takeda
  2. 6.1.1 Takeda Company Information
  3. 6.1.2 Takeda Business Overview
  4. 6.1.3 Takeda IVIg Liquid Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Takeda IVIg Liquid Product Portfolio
  6. 6.1.5 Takeda Recent Developments
  7. 6.2 Sichuan Yuanda Shuyang
  8. 6.2.1 Sichuan Yuanda Shuyang Company Information
  9. 6.2.2 Sichuan Yuanda Shuyang Business Overview
  10. 6.2.3 Sichuan Yuanda Shuyang IVIg Liquid Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sichuan Yuanda Shuyang IVIg Liquid Product Portfolio
  12. 6.2.5 Sichuan Yuanda Shuyang Recent Developments
  13. 6.3 Shanghai RAAS
  14. 6.3.1 Shanghai RAAS Company Information
  15. 6.3.2 Shanghai RAAS Business Overview
  16. 6.3.3 Shanghai RAAS IVIg Liquid Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Shanghai RAAS IVIg Liquid Product Portfolio
  18. 6.3.5 Shanghai RAAS Recent Developments
  19. 6.4 Hualan Bio
  20. 6.4.1 Hualan Bio Company Information
  21. 6.4.2 Hualan Bio Business Overview
  22. 6.4.3 Hualan Bio IVIg Liquid Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Hualan Bio IVIg Liquid Product Portfolio
  24. 6.4.5 Hualan Bio Recent Developments
  25. 6.5 Octapharma
  26. 6.5.1 Octapharma Company Information
  27. 6.5.2 Octapharma Business Overview
  28. 6.5.3 Octapharma IVIg Liquid Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Octapharma IVIg Liquid Product Portfolio
  30. 6.5.5 Octapharma Recent Developments
  31. 6.6 LFB Group
  32. 6.6.1 LFB Group Company Information
  33. 6.6.2 LFB Group Business Overview
  34. 6.6.3 LFB Group IVIg Liquid Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 LFB Group IVIg Liquid Product Portfolio
  36. 6.6.5 LFB Group Recent Developments
  37. 6.7 Kedrion
  38. 6.7.1 Kedrion Company Information
  39. 6.7.2 Kedrion Business Overview
  40. 6.7.3 Kedrion IVIg Liquid Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Kedrion IVIg Liquid Product Portfolio
  42. 6.7.5 Kedrion Recent Developments
  43. 6.8 Grifols
  44. 6.8.1 Grifols Company Information
  45. 6.8.2 Grifols Business Overview
  46. 6.8.3 Grifols IVIg Liquid Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Grifols IVIg Liquid Product Portfolio
  48. 6.8.5 Grifols Recent Developments
  49. 6.9 CSL
  50. 6.9.1 CSL Company Information
  51. 6.9.2 CSL Business Overview
  52. 6.9.3 CSL IVIg Liquid Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 CSL IVIg Liquid Product Portfolio
  54. 6.9.5 CSL Recent Developments
  55. 6.10 CNBG
  56. 6.10.1 CNBG Company Information
  57. 6.10.2 CNBG Business Overview
  58. 6.10.3 CNBG IVIg Liquid Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 CNBG IVIg Liquid Product Portfolio
  60. 6.10.5 CNBG Recent Developments
  61. 6.11 CBPO
  62. 6.11.1 CBPO Company Information
  63. 6.11.2 CBPO Business Overview
  64. 6.11.3 CBPO IVIg Liquid Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 CBPO IVIg Liquid Product Portfolio
  66. 6.11.5 CBPO Recent Developments
  67. 6.12 BPL
  68. 6.12.1 BPL Company Information
  69. 6.12.2 BPL Business Overview
  70. 6.12.3 BPL IVIg Liquid Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 BPL IVIg Liquid Product Portfolio
  72. 6.12.5 BPL Recent Developments
  73. 6.13 Biotest
  74. 6.13.1 Biotest Company Information
  75. 6.13.2 Biotest Business Overview
  76. 6.13.3 Biotest IVIg Liquid Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Biotest IVIg Liquid Product Portfolio
  78. 6.13.5 Biotest Recent Developments
7 North America by Country
  1. 7.1 North America IVIg Liquid Sales by Country
  2. 7.1.1 North America IVIg Liquid Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America IVIg Liquid Sales by Country (2021-2026)
  4. 7.1.3 North America IVIg Liquid Sales Forecast by Country (2027-2032)
  5. 7.2 North America IVIg Liquid Market Size by Country
  6. 7.2.1 North America IVIg Liquid Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America IVIg Liquid Market Size by Country (2021-2026)
  8. 7.2.3 North America IVIg Liquid Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe IVIg Liquid Sales by Country
  2. 8.1.1 Europe IVIg Liquid Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe IVIg Liquid Sales by Country (2021-2026)
  4. 8.1.3 Europe IVIg Liquid Sales Forecast by Country (2027-2032)
  5. 8.2 Europe IVIg Liquid Market Size by Country
  6. 8.2.1 Europe IVIg Liquid Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe IVIg Liquid Market Size by Country (2021-2026)
  8. 8.2.3 Europe IVIg Liquid Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific IVIg Liquid Sales by Country
  2. 9.1.1 Asia-Pacific IVIg Liquid Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific IVIg Liquid Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific IVIg Liquid Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific IVIg Liquid Market Size by Country
  6. 9.2.1 Asia-Pacific IVIg Liquid Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific IVIg Liquid Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific IVIg Liquid Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America IVIg Liquid Sales by Country
  2. 10.1.1 South America IVIg Liquid Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America IVIg Liquid Sales by Country (2021-2026)
  4. 10.1.3 South America IVIg Liquid Sales Forecast by Country (2027-2032)
  5. 10.2 South America IVIg Liquid Market Size by Country
  6. 10.2.1 South America IVIg Liquid Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America IVIg Liquid Market Size by Country (2021-2026)
  8. 10.2.3 South America IVIg Liquid Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa IVIg Liquid Sales by Country
  2. 11.1.1 Middle East and Africa IVIg Liquid Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa IVIg Liquid Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa IVIg Liquid Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa IVIg Liquid Market Size by Country
  6. 11.2.1 Middle East and Africa IVIg Liquid Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa IVIg Liquid Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa IVIg Liquid Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 IVIg Liquid Value Chain Analysis
  2. 12.1.1 IVIg Liquid Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 IVIg Liquid Production Mode & Process
  7. 12.2 IVIg Liquid Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 IVIg Liquid Distributors
  10. 12.2.3 IVIg Liquid Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research